3-O-(2'E ,4'E-decadienoyl)-20-O-acetylingenolCAS# 466663-12-7 |
- 3-O-(2'E ,4'Z-decadienoyl)-20-O-acetylingenol
Catalog No.:BCN1550
CAS No.:158850-76-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 466663-12-7 | SDF | Download SDF |
PubChem ID | 102004598 | Appearance | Powder |
Formula | C32H44O7 | M.Wt | 540.7 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)COC(=O)C)O)O)C | ||
Standard InChIKey | SYXKKJDQNXPUSI-OJHJWTESSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 3-O-(2′E,4′E-decadienoyl)-20-O-acetylingenol has strong cytotoxicity against human normal cell lines L-O2 and GES-1 with dose-dependent relationships. |
3-O-(2'E ,4'E-decadienoyl)-20-O-acetylingenol Dilution Calculator
3-O-(2'E ,4'E-decadienoyl)-20-O-acetylingenol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.8495 mL | 9.2473 mL | 18.4945 mL | 36.9891 mL | 46.2364 mL |
5 mM | 0.3699 mL | 1.8495 mL | 3.6989 mL | 7.3978 mL | 9.2473 mL |
10 mM | 0.1849 mL | 0.9247 mL | 1.8495 mL | 3.6989 mL | 4.6236 mL |
50 mM | 0.037 mL | 0.1849 mL | 0.3699 mL | 0.7398 mL | 0.9247 mL |
100 mM | 0.0185 mL | 0.0925 mL | 0.1849 mL | 0.3699 mL | 0.4624 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3-O-(2'E,4'E-Decadienoyl)ingenol
Catalog No.:BCN3768
CAS No.:466663-11-6
- Arteminin
Catalog No.:BCN3642
CAS No.:466639-11-2
- Cryptomeridiol
Catalog No.:BCN5516
CAS No.:4666-84-6
- Rauvomitin
Catalog No.:BCN3421
CAS No.:466-57-9
- Bullatine B
Catalog No.:BCN2375
CAS No.:466-26-2
- Benzoylaconine
Catalog No.:BCN5400
CAS No.:466-24-0
- Uzarigenin
Catalog No.:BCN5515
CAS No.:466-09-1
- Proscillaridin A
Catalog No.:BCC8239
CAS No.:466-06-8
- Hedragonic acid
Catalog No.:BCN6911
CAS No.:466-02-4
- Hederagonic acid
Catalog No.:BCN5514
CAS No.:466-01-3
- Cycloartanol
Catalog No.:BCN4860
CAS No.:4657-58-3
- alpha-Spinasterol acetate
Catalog No.:BCN5510
CAS No.:4651-46-1
- Z-Asp-OMe
Catalog No.:BCC2792
CAS No.:4668-42-2
- N-Methylcorydiniumiodide
Catalog No.:BCN7873
CAS No.:4668-64-6
- Hecogenin
Catalog No.:BCN5408
CAS No.:467-55-0
- Coronaridine
Catalog No.:BCN3762
CAS No.:467-77-6
- Rehmannic acid
Catalog No.:BCN4632
CAS No.:467-81-2
- Theaflavin
Catalog No.:BCN5419
CAS No.:4670-05-7
- Alvespimycin
Catalog No.:BCC1346
CAS No.:467214-20-6
- 17-DMAG (Alvespimycin) HCl
Catalog No.:BCC1175
CAS No.:467214-21-7
- Diphenyleneiodonium chloride
Catalog No.:BCC6670
CAS No.:4673-26-1
- Nootkatone
Catalog No.:BCN5517
CAS No.:4674-50-4
- Lu AE58054 Hydrochloride
Catalog No.:BCC1708
CAS No.:467458-02-2
- Lu AE58054
Catalog No.:BCC1707
CAS No.:467459-31-0
Bio-guided isolation of the cytotoxic terpenoids from the roots of Euphorbia kansui against human normal cell lines L-O2 and GES-1.[Pubmed:23109850]
Int J Mol Sci. 2012;13(9):11247-59.
The dried roots of Euphorbia kansui (kansui) have been used for centuries in China as a herbal medicine for edema, ascites, and asthma. The 95% ethanol extract showed a significant inhibition of cell proliferation against human normal cell lines L-O2 and GES-1. Bioassay-guided separation of the 95% ethanol extract from the roots of E. kansui led to the isolation of 12 diverse terpenoids whose structures were identified by (1)H, (13)C NMR spectroscopy and ESI-MS as kansuinine A (1), kansuinine B (2), kansuinine C (3), kansuiphorin C (4), 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol (5), 3-O-(2'E,4'Edecadienoyl)-20-O-acetylingenol (6), 3-O-(2'E,4'Z-decadienoyl)-20-deoxyingenol (7), 3-O-benzoyl-20-deoxyingenol (8), 5-O-benzoyl-20-deoxyingenol (9), kansenone (10), epi-kansenone (11), euphol (12). All these 12 terpernoids were evaluated in vitro for cytotoxicity on L-O2 and GES-1 cell lines. Most ingenane-type diterpenoids and 8-ene-7-one triterpenoids (5-11) exhibited a relatively lower IC(50) value; therefore, these compounds had stronger cytotoxicity against human normal cell lines L-O2 and GES-1 with dose-dependent relationships. These results will be significantly helpful to reveal the mechanism of toxicity of kansui and to effectively guide safer clinical application of this herb.